American Vietnamese Biotech Incorporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was VND 42,933.48 million compared to VND 47,696.93 million a year ago. Net income was VND 3,385.1 million compared to VND 12,312.53 million a year ago.

Basic earnings per share from continuing operations was VND 26 compared to VND 135 a year ago. Diluted earnings per share from continuing operations was VND 26 compared to VND 135 a year ago.